back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-06-04 10:37 Tx date 2026-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,412 vol |
150,022 | |
| Older filings | ||||||
| Filed 2026-04-17 17:24 Tx date 2026-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+3,355 vol |
35,176 | |
| Filed 2026-04-17 17:23 Tx date 2025-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+5,290 vol |
31,821 | |
| Filed 2026-04-17 17:22 Tx date 2024-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+9,375 vol |
26,531 | |
| Filed 2026-04-17 17:22 Tx date 2023-01-03 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+17,156 vol |
17,156 | |
| Filed 2026-04-17 17:21 Tx date 2021-07-15 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-17 17:21 Tx date 2022-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+13,222 vol |
32,008 | |
| Filed 2025-06-03 15:31 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+32,162 vol |
96,388 | |
| Filed 2024-06-18 15:42 Tx date 2024-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+28,472 vol |
64,226 | |
| Filed 2023-06-26 12:38 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$49,997
+12,787 vol $3.91 each |
12,787 | |
| Filed 2023-06-26 12:38 Tx date 2021-07-15 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-05 16:55 Tx date 2023-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+16,968 vol |
35,754 | |
| Filed 2021-07-23 20:46 Tx date 2021-07-15 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$68,381
+18,786 vol $3.64 each |
18,786 | |
| Filed 2021-07-23 20:45 Tx date 2021-07-15 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||